PRO1107 in Patients With Advanced Solid Tumors
Genmab
Genmab
Ocellaris Pharma, Inc.
Seagen Inc.
Fusion Pharmaceuticals Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Incyte Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Numab Therapeutics AG
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Numab Therapeutics AG
Pfizer
NextCure, Inc.
Elevation Oncology
Valerio Therapeutics
Seagen Inc.
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Novartis
Five Prime Therapeutics, Inc.
Tango Therapeutics, Inc.
NantCell, Inc.
ADC Therapeutics S.A.
Ikena Oncology
Haihe Biopharma Co., Ltd.
Gilead Sciences
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Tesaro, Inc.
National Institutes of Health Clinical Center (CC)
Duke University
MacroGenics
University of Pennsylvania
Dr. Horst Schmidt Klinik GmbH
ExcellaBio LLC
Incyte Corporation
Syros Pharmaceuticals
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)